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Abstract 
A simple, precise, accurate, simultaneous stability indicating RP-HPLC method for the estimation of IBU 
(Ibuprofen) and FMT (Famotidine) in combined dosage form was developed using Grace RP-C18 (4.6 x 250mm, 5µm) in 
an gradient mode with mobile phase comprising of Methanol: Water (pH 2.5 using OPA) The flow rate was 0.7 mL/ min 
and effluent was monitored at 240.0 nm. The retention times were found to be 6.68 min for IBU and 1.76 min for FMT. 
The assay exhibited a linear dynamic range of 30- 150 µg/mL for IBU and 1- 5 µg/mL for FMT. The calibration curves 
were linear (r
2
 = 0.994 for IBU and r
2
 = 0.997 for FMT) over the entire linear range. Mean % recovery was found to be 
99.82 % for IBU and 99.91 % for FMT with % RSD was NMT 2 for both estimations which fully agrees with system 
suitability which is in good agreement with labeled amount of formulation. The % RSD for Intra- Day & Inter-Day 
Precision was NMT than 2 for both the drugs. The developed method was validated as per ICH guidelines. 
Keywords: IBU, FMT, RP-HPLC, Assay method, Method Validation. 
 
1. Introduction 
The technique High Performance Liquid 
Chromatography (HPLC) is so called because of its 
improved performance over the classical column 
chromatography. The technique basically involves the use 
of porous material as a stationary phase and the liquid 
mobile phase is pumped into the column under high 
pressure. The development of this technique is attributed to 
the small particle size of stationary phase. As the particle 
size is small the resistance to the flow of mobile phase is 
very high that is the reason why the high pressure is 
recommended.[1, 18] Analytical method development and 
validation are key elements of any pharmaceutical 
development program. HPLC analysis method is developed 
to identify, quantity or purifying compounds of interest. 
This technical brief will focus on development and 
validation activities as applied to drug products. Method 
validation is the process of proving that an analytical 
method is acceptable for its intended purpose. The 
parameters for method validation as defined by ICH 
(International Conference on Harmonization) guidelines 
are Accuracy, Precision, Specificity, Limit of Detection, 
Limit of Quantitation, Linearity, Range, Robustness and 
Ruggedness
2
. From the literature review [7-16] it has been 
found that only three analytical methods for the above 
combination have been reported. Therefore the attempt is 
made to develop simple, accurate, precise rapid and 
economical RP-HPLC method for determination of 
Ibuprofen (IBU) and Famotidine (FMT) in combine dosage 
form. Ibuprofen [Figure 1]. Chemically is (RS)-2-(4-(2- 
methylpropyl) phenyl) propanoic acid. It is white crystalline 
powder used as analgesic having solubility in methanol, 
ethanol and in water 21 mg/Lt. While famotidine [Figure 2] 
chemically is 3-[({2-[(diaminomethylidene)amino]-1,3-
thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimid 
amide.[5,6,19,20] It is white to pale yellow crystalline. 
Used as anti-ulcer having solubility in methanol and freely 
soluble in glacial acetic acid, slightly soluble in water.  
 
Figure 1: Chemical Structure of Ibuprofen 
 
Figure 2: Chemical Structure of Famotidine 
2. Experimental 
2.1 Reagents & Chemicals 
Standard samples of IBU & FMT were received as 
gift samples from The Leben Laboratories Akola 
(Maharashtra) and Taj Pharmaceuticals, Mumbai 
(Maharashtra). The marketed formulation Duexis (Horizon 
Pharma) was purchased from the local market containing 
IBU 800 mg and FMT 26.6 mg and all the chemicals used 
were are of analytical grade. 
2.2 Instruments 
HPLC System of Younglin Quaternary pump with 
UV- VIS detector (190-990 nm) Software – Autochro. 
Analytical balance of citizen model CY 104 
(microanalytical balance) was used for weighing purpose 
also the ultrasonicator servewell instruments model RC-
SYSTEM MU-1700 used for sonication purpose. 
2.3 Preparation of Standard Solutions 
Standard Stock Solution (A): Accurately weighed 
quantity of IBU (30.0 mg) was transferred to 50.0 mL 
volumetric flask and dissolved in methanol. The volume 
was made up to mark with methanol to get final 
concentration of 600 µg/mL. The resultant solution was 
then sonicated for 10.0 min in ultrasonicator. 
Standard Stock Solution (B) Accurately weighed quantity 
of FMT (10.0 mg) was transferred to 50.0 mL volumetric 
flask and dissolved in methanol. The volume was made up 
to mark with methanol to get final concentration of 200 
µg/mL. The resultant solution was then sonicated for 10.0 
min in ultrasonicator. 
Working Standard Solution (C) 0.5 mL of solution (A) 
and 0.05 mL of solution (B) was transferred to 10.0 mL 
volumetric flask and then the volume was made up to the 
mark with mobile phase to get final concentration of (30.0 
µg/mL of IBU & 1.0 µg/mL of FMT) respectively. The 
resultant solution was then sonicated for 10.0 min in 
ultrasonicator. 
2.4 Optimization of Mobile Phase and 
Chromatographic Conditions 
Procedure: The chromatographic conditions were set as 
per the optimized parameters. The mobile phase was 
allowed to equilibrate with stationary phase as was 
indicated by a steady baseline. Solution (C) was injected in 
the Rheodyne injector (20.0 µl) and the respective 
chromatograms were recorded. Various mobile phases 
were tried by permutations and combinations and also by 
varying column, flow rate, column temperature and type of 
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buffers with varying pH and solvents. The various mobile 
phases tried are as follows. 
 Trial 1 Methanol: Water (70: 30) pH 7 
 Trial 2 Methanol: Water (75: 25) pH 7 
 Trial 3 Methanol: Water (80:20) pH 7 
 Trial 4 Methanol: Water (85: 15) pH 2.5 
Above mentioned mobile phases were tried. The mobile 
phase containing Methanol: water (85: 15) at pH 2.5, 
injection volume- 20.0 µL flow rate of 0.7 mL/min was 
selected, due to its high resolving power, sensitivity and 
suitability, for the determination of IBU and FMT. The 
chromatogram is shown in Figure 3. Hence the following 
optimized chromatographic parameters were selected to 
carry out further experimentation. 
 Column          : Grace RP-C18 (4.6 x 250mm, 5µm) 
 Flow Rate      : 0.7 mL/min 
 Wavelength   : 240.0 nm 
 Injection Volume         : 20.0 µL 
 Column Temperature : Ambient 
 Run Time       : 10.0 min 
 Mobile Phase : Methanol: Water (85:15) 
 pH                   : 2.5 (Using OPA) 
2.5 System Suitability Studies 
System suitability is a pharmacopoeial requirement 
and is used to verify, whether the resolution and 
reproducibility of the chromatographic system are adequate 
for analysis to be carried out. It is performed to ensure that 
the system is operating properly and read to deliver results 
with acceptable accuracy and precision. The tests were 
performed by collecting data from five replicate injections of 
standard solutions. 
Procedure: The chromatographic conditions were set as 
per the optimized parameters and mobile phase was 
allowed to equilibrate with stationary phase as was 
indicated by the steady baseline. Five replicate injections of 
mixed working standard solution (C) were injected in to the 
system, the chromatograms were recorded for both the 
drugs and the results are shown in Table 1 & 2. 
2.6 Analysis of Standard Laboratory Mixtures 
2.6.1 Preparation of Standard Laboratory Mixtures 
(Standard) 
IBU Standard Stock Solution (A): Accurately weighed 
quantity of IBU (30.0 mg) was transferred to 50.0 mL 
volumetric flask and dissolved in methanol. The volume 
was made up to mark with methanol to get final 
concentration of (600 µg/mL of IBU). The resultant 
solution was then sonicated for 10.0 min in ultrasonicator. 
FMT Standard Stock Solution (B): Accurately weighed 
quantity of FMT (10.0 mg) was transferred to 50.0 mL 
volumetric flask and dissolved in methanol. The volume 
was made up to mark with methanol to get final 
concentration of (200 µg/mL of FMT). The resultant 
solution was then sonicated for 10.0 min in ultrasonicator. 
Mixed Standard Solutions: 0.5 mL of solution (A) and 
0.05 mL of solution (B) was then transferred to 10.0 mL 
volumetric flask and volume was made up to the mark with 
mobile phase to get final concentration of (30.0 µg/mL of 
IBU & 1.0 µg/mL of FMT) respectively.  
2.6.2 Preparation of Standard Laboratory Mixtures 
(Sample) 
Accurately weighed 800.0 mg of IBU and 26.6 mg 
of FMT (as per labeled requirement of marketed 
formulation) was transferred to 50.0 mL volumetric flask 
and dissolved in sufficient quantity of methanol. Then the 
volume was made up to the mark with methanol. The 
resultant solution was then sonicated in ultrasonicator for 
10.0 min. then aliquot portions of 0.0075 mL and 0.0057 
mL was then transferred to two separate 10.0 mL 
volumetric flask and then volume was made up to the mark 
with mobile phase to get final concentrations of (120.0 
µg/mL & 90.0 µg/mL of IBU and 4.0 µg/mL & 3.0 µg/mL 
of FMT) respectively. The peak area of standard laboratory 
mixture and sample laboratory mixture was compared to 
obtain the concentration. The amount of each drug 
estimated in laboratory mixture was calculated using 
following formula –  
                                                          At          Ds          Ws 
                       % Estimation                      x              x            
x 100    
                                                          As           Dt          Wt 
   Where, 
                At   =         Area count for sample solution 
As =        Area count for standard solution 
Ds =        Dilution factor for standard  
Dt =        Dilution factor for sample 
Ws =       Weight of standard (mg) 
Wt =        Weight of sample (mg) 
The results are shown in Table 3. 
2.7 Analysis of Marketed Formulation 
2.7.1 Preparation of Standard Solutions  
Prepared as per the methodology adopted for 
laboratory mixtures 
2.7.2 Preparation of Sample Solutions 
Ten Tablets were weighed accurately and ground 
to fine powder. An accurately weighed quantity of Tablet 
powder equivalent to (800 mg of IBU & 26.6 mg of FMT) 
were transferred to 50.0 mL of volumetric flask and 
dissolved in sufficient amount of methanol. Then the 
volume was made up to the mark with methanol. The 
resultant solution was then filtered through whatman filter 
paper (no. 41). The filtered solution was then sonicated in 
ultrasonicator for 10.0 min. aliquot portions of 0.0075 mL 
was then transferred to the three separate 10.0 mL 
volumetric flask and then the volume was mad up to the 
mark with mobile phase to get final concentration of (120.0 
µg/mL of IBU and 4.0 µg/mL of FMT) respectively. 
Procedure: Equal volume (20.0 L) of standard and 
sample solution was injected separately after equilibrium of 
stationary phase. The chromatograms were recorded and 
the response i.e. peak area of major peaks were measured. 
The amount of drug in a Tablet was calculated using 
following formula 
                       AT1 x WS1 x Ds x P1 
mg/Tablet = -------------------------------- x Avg. wt 
                       AS1 x WT x Dt 
Where,  
AT1= Average area of IBU/FMT peaks in Test 
chromatogram 
AS1 = Average area of IBU/FMT peaks in Standard 
chromatogram 
Ds = Dilution factor for standard 
Dt = Dilution factor for test 
P1 = Potency of working standards of IBU/FMT of % w/w 
basis 
Avg. wt = Average weight of 10 Tablets 
Further calculate the amount of IBU/FMT present in % of 
Label claim using following formula 
                               Assay (mg/Tablet) x 100 
% Label Claim =   ------------------------------------ 
                               Label claim of IBU/FMT 
 
The results are shown in Table 4, while 
chromatogram is shown in Figure 4. 
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2.8 Method Validation  
1. Linearity 
Preparation of Standard Solutions 
IBU Standard Stock Solution (A): Accurately weighed 
quantity of IBU (30.0 mg) was transferred to 50.0 mL 
volumetric flask and dissolved in methanol. The volume 
was made up to mark with methanol to get final 
concentration of (600 µg/mL of IBU). The resultant 
solution was then sonicated for 10.0 min in ultrasonicator. 
FMT Standard Stock Solution (B): Accurately weighed 
quantity of FMT (10.0 mg) was transferred to 50.0 mL 
volumetric flask and dissolved in methanol. The volume 
was made up to mark with methanol to get final 
concentration of (200 µg/mL of FMT). The resultant 
solution was then sonicated for 10.0 min in ultrasonicator. 
Mixed Standard Solutions: aliquots portions of 0.5 to 2.5 
mL from the standard stock solutions A and  aliquots 
portions of 0.05 to 0.25 mL from the standard stock 
solution B were transferred to five 10.0 mL volumetric 
flasks and then volume was made up to the mark with 
mobile phase to get 5 different mixed standard solutions 
having concentrations of (30.0:1.0, 60.0:2.0, 90.0:3.0, 
120.0:4.0, 150.0:5.0 µg/mL of IBU & FMT) respectively. 
The resultant solutions was then sonicated in ultrasonicator 
for 10.0 min 
Procedure: Equal volumes (20.0 L) of 5 mixed standard 
solutions were injected separately after equilibrium of 
stationary phase. The chromatograms were recorded and 
the response i.e. peak area of major peaks were measured. 
Then calibration curve (Peak area vs concentration) was 
plotted and it is shown in Figure 5 & 6. The observations 
are shown in Table 5. 
2. Accuracy 
Preparation of Standard Solutions: Standard solutions of 
(IBU & FMT) were prepared at the level of 80 %, 10.00 %, 
120 %.  
Preparation of Sample Solution: To the preanalysed 
sample solution (60 µg/mL of IBU & 2 µg/mL of FMT) a 
known amount of standard solutions of pure drugs (IBU & 
FMT) were added in different levels i.e. 80%, 10.00 %, 
120%. The results of recovery studies shown in Table 6. 
The percent recovery was then calculated by using formula; 
                                   Ew - B 
       % Recovery =   ----------   X 100 
                            C 
Where,  
Ew = Total drug estimated (mg) 
B= Amount of drug contributed by pre analyzed Tablet 
powder (mg)                                        
C= Weight of pure drug added (mg) 
3. Precision  
3.1 Intra-Day Precision  
It was determined by analyzing the 3 different 
solutions having concentration (90.0 µg/mL of IBU & 3.0 
µg/mL of FMT) at 3 different times over a period of day. 
3.2 Inter-Day Precision 
It was determined by analyzing the 3 different 
solutions having concentration (90.0 µg/mL of IBU & 3.0 
µg/mL of FMT) at 3 days over a period of week. 
Procedure: Equal volumes (20.0 L) of these solutions 
were injected separately after equilibrium of stationary 
phase. The chromatograms were recorded and the response 
i.e. peak areas, retention time of major peaks were 
measured. The results are shown in Table 7. 
4. Robustness  
Preparation of Sample Solution: Sample solution of 
marketed formulation was prepared as per the methodology 
adopted for marketed formulation analysis. 
Procedure: Equal volume (20.0 L) of sample solution 
was injected separately after equilibrium of stationary 
phase. Then deliberate variation in method parameters such 
as flow rate (<0.2mL/min), change in detection wavelength 
(<2 nm) was carried out. The chromatograms were 
recorded and the response i.e. peak area, retention time of 
the major peaks were measured. The results are shown in 
Table 8 & 9 chromatograms are shown in Figure 14 & 15. 
5. Ruggedness  
Ruggedness of the method was studied by two 
different analysts using same operational and 
environmental conditions. A sample solutions prepared as 
per the methodology adopted in section 5.2 having 
concentration (120.0 µg/mL of IBU & 4.0 µg/mL of FMT) 
respectively, were analyzed and concentrations were 
determined. The results are shown in Table 10 & 11. 
 
3. Results and Discussion 
3.1 Optimization of Mobile Phase and Chromatographic Conditions 
 
Figure 3: Optimized Chromatogram of IBU & FMT 
Observation 
Good resolution with minimized tailing also proper peak shape and system suitability was observed within the 
limits. Hence the above chromatographic parameters are finalized.  
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3.2 System Suitability Studies 
Table 1 Result of System Suitability Studies for (IBU) 
System Suitability Test (IBU) 
Sr. No Area Reproducibility Retention Time Tailing Factor Resolution Theoretical Plates 
1 3086.20 6.616 1.348 19.00 6851 
2 3083.11 6.612 1.344 19.05 6852 
3 3088.31 6.641 1.352 19.01 6822 
4 3087.25 6.661 1.325 18.99 6872 
5 3086.16 6.651 1.331      19.00 6378 
Mean 3086.206 6.6362 1.3364 19.01 6755.2 
%RSD 0.019 0.679 1.026 0.573 1.812 
Limit NMT 2% NMT 1% < 2 > 2 > 2000 
 
Observation 
All the parameters of system suitability are observed within the limits for IBU. 
Table 2 Results of System Suitability Studies for (FMT) 
System Suitability Test (FMT) 
Sr. No Area Reproducibility Retention Time Tailing Factor Resolution Theoretical plates 
1 82.4619 1.816 1.205 0 3605.9 
2 83.4516 1.912 1.221 0 3604.1 
3 82.4618 1.901 1.252 0 3606.1 
4 83.4612 1.951 1.241 0 3605 
5 82.4722 1.916 1.224 0 3609 
Mean 82.4617 1.9192 1.2348 0 3606.02 
%RSD 1.32 0.318 1.117 0 0.0594267 
Limit NMT 2% NMT 1% < 2 > 2 > 2000 
 
Observation  
All the parameters of system suitability are observed within the limits for FMT. 
3.3 Analysis of Standard Laboratory Mixtures 
Table 3 Results of Analysis of Standard Laboratory Mixtures 
Average Wt.=796 mg 
Std weight(mg) 
Sample 
Area of Std Area of Sample  
weight (mg) % Labeled Claim 
IBU FMT   IBU FMT IBU FMT IBU FMT 
120.0 4 
794 
5817.66 173.802 
5953.49 124.33 99.83 99.92 
796 5958.68 128.36 99.87 99.64 
798 5956.82 125.16 99.85 98.94 
 
3.4 Analysis of Marketed Formulation 
Table 4 Results of Marketed Formulation Analysis 
Sr. No. 
IBU FMT 
Assay (mg) Assay (%) Assay (mg) Assay (%) 
1 120.85 99.83 4.47 99.91 
2 119.24 99.83 4.49 99.92 
3 119.02 99.80 4.46 99.91 
Mean 119.70 99.82 4.47 99.913333 
SD 0.1138 0.024119 0.3510 0.04520 
% RSD 0.061 0.648763 0.35 0.417598 
 
 
Figure 4: Chromatogram of Marketed Formulation 
The proposed method was applied to the determination of IBU & FMT in marketed formulation the mean % 
amount found was 99.82 (IBU) & 99.91 (FMT) with % RSD values is NMT 2.0% indicates the developed method was 
successfully applied for analysis of marketed formulation. All the results found are in good agreement with the label 
content of marketed formulation.  
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3.5 Method Validation 
[1] Linearity 
 
Figure 5: Calibration Curve of IBU 
 
Figure 6: Calibration Curve of FMT 
 
Table 5: Linearity Studies of IBU & FMT 
Concentration (µg/mL) Peak Area 
IBU FMT IBU FMT 
30 1 1493.371 44.87 
60 2 3032.038 97.92 
90 3 4285.055 137.02 
120 4 5455.017 178.06 
150 5 6484.243 224.97 
 
Mean 6149.9448 136.568 
SD 123.88 1.18 
%RSD 1.62 0.62 
 
In both calibration curves the r
2
 value was found to be 0.997 which nearly equals to unity. The regression equation 
for IBU was y = 41.34x + 428.5 while for FMT it was y = 44.03x + 4.464. It indicates the capability of developed method 
to estimate both the drugs over the desired concentration range.  
 
Figure 7 Linearity Chromatogram for (30 µg/mL of IBU & 1 µg/mL of FMT) 
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Figure 8 Linearity Chromatogram for (60 µg/mL of IBU & 2 µg/mL of FMT) 
 
Figure 9 Linearity Chromatogram for (90 µg/mL of IBU & 3 µg/mL of FMT) 
 
Figure 10 Linearity Chromatogram for (120 µg/mL of IBU & 4 µg/mL of FMT) 
 
Figure 11 Linearity Chromatogram for (150 µg/mL of IBU & 5 µg/mL of FMT) 
2. Accuracy 
This is performed on the basis of recovery studies by standard addition method. Standard solutions of pure drugs 
(IBU & FMT) were added in different levels i.e. 80%, 100 %, 120%. 
 
Table 6: Results of Recovery Studies 
Level of 
% 
Recovery 
Amount present 
(mg/tab) 
Amount taken 
(μg/ml) 
Amount of Std. 
Drug 
Added(μg/ml) 
Total Amount 
Recovered (μg/ml) 
%Recovery 
 
IBU FMT IBU FMT IBU FMT IBU FMT IBU FMT 
80% 
800 27 60 2 48 1.6 799.11 27.09 98.77 98.63 
800 27 60 2 48 1.6 798.23 27.16 98.77 98.82 
800 27 60 2 48 1.6 800.12 26.87 98.56 98.56 
100% 
800 27 60 2 60 2 799.63 26.23 99.09 98.82 
800 27 60 2 60 2 800.09 27.36 99.54 99.15 
800 27 60 2 60 2 800.87 27.89 99.63 98.37 
120% 
800 27 60 2 72 2.4 802.15 26.23 97.84 98.91 
800 27 60 2 72 2.4 799.87 27.32 97.74 99.03 
800 27 60 2 72 2.4 798.99 26.08 97.81 98.98 
 
The mean % recovery with % RSD for IBU was found to be 98.63, 0.195 and for FMT it was 98.54, 0.147. The 
% RSD not more than 2 which fully agrees with system suitability hence the developed RP-HPLC method was found to be 
sufficiently accurate. 
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3. Precision 
Table 7: Results of Precision Studies 
Sr. No. IBU FMT 
 Peak Area Sample  %Assay  
 
Peak Area 
Sample 
%Assay  
 
1 4406.381 98.41 138.66 99.99 
2 4404.452 98.39 133.23 99.98 
3 4402.541 98.34 132.98 99.82 
4 4401.214 98.33 133.45 99.97 
5 4403.675 98.37 132.89 99.86 
6 4405.012 98.40 133.21 99.92 
 Mean  98.37333333 Mean  99.923333 
 SD 0.32659863 SD 0.188984 
 %RSD 0.32865822 %RSD 0.1859337 
 
Precision was determined by peak area. Reproducibility in retention time and peak area is observed in precision 
studies with a %RSD (NMT than 2%) for both retention time and peak area which is in agreement with system suitability. 
Therefore, the proposed HPLC method for the determination of IBU and FMT was found to be sufficiently precise. 
4. Robustness 
Table 8: Robustness studies of IBU 
Condition Mean ± SD n=3 %RSD 
Change in flow rate (± 0.1 ml) 7624.83 123.88 1.62 
Change in detection wavelength (± 2 nm) 7268.08 80.75 1.11 
 
Table 9: Robustness studies of FMT 
Condition Mean ± SD n=3 %RSD 
Change in flow rate (± 0.1 ml) 259.79 1.18 0.62 
Change in detection wavelength (± 2 nm) 263.03 1.52 0.58 
 
 
Figure 12 Chromatogram of Robustness (<0.1mL/min) 
 
Figure 13: Chromatogram of Robustness (<2.0 nm) 
The results of assay of test solution was not get affected by varying the conditions. They are fully agree with the 
results obtained under original conditions. The % RSD for (Retention time, Peak area and % Amount Found) was not 
more than 2% for both (IBU & FMT) which was in agreement with system suitability. Hence the proposed HPLC method 
for the determination of IBU and FMT in a tablet was found to be robust. 
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5. Ruggedness                        
 Table 10: Results of ruggedness study for IBU 
Sr. No 
 
Observations 
% Drug estimation 
Intra-day Inter-day Different Analyst 
1 I 99.612 98.822 98.932 
2 II 99.51 99.447 99.530 
3 III 99.512 99.324 99.676 
Mean 99.547 99.264 99.573 
±S.D. 0.0550 0.309 0.493 
%R.S.D. 0.0553 0.313 0.495 
 
Table 11: Results of ruggedness study for FMT 
Sr. No Observations 
% Drug estimation 
Intra-day Inter-day 
Different 
Analyst 
1 I 98.712 98.824 98.876 
2 II 99.622 99.657 99.624 
3 III 99.543 99.722 99.922 
Mean 99.393 99.397 99.472 
±S.D. 0.578 0.581 0.474 
%R.S.D. 0.590 0.585 0.476 
Ruggedness was determined as Intra-day, Inter-day & Different Analyst. % amount of drugs were found with % 
RSD (NMT than 2%) which was in agreement with system suitability. Therefore, the proposed HPLC method for the 
determination of IBU and FMT in a tablet was found to be sufficiently rugged. 
 
4. Conclusion 
The developed RP-HPLC method was found to be 
linear over wider concentration range. Therefore the 
developed RP-HPLC method can be applied for routine 
quantitative and qualitative analysis of IBU and FMT in 
bulk and pharmaceutical formulations like tablets. This 
method was also used to check quality of product after 
different storage condition and when stress degradation is 
carried out. The developed RP-HPLC method was 
validated as per the ICH guidelines. The developed RP-
HPLC method has a stability indicating nature hence the 
proposed method could be employed for the stability 
studies on pharmaceutical preparations within 
pharmaceutical industry. 
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